Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01324752 · ClinicalTrials.gov registry record · Phase 1
A Drug-Drug Interaction Study of Losartan and PA21
A Phase 1 study, sponsored by Vifor Pharma.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT01324752 is a Phase 1 study that has completed, run by Vifor Pharma. The registered enrollment target is 36 participants.
The verdict
NCT01324752, a Phase 1 study, has completed, sponsored by Vifor Pharma.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if Losartan potassium is affected by PA21.
Interventions
- DRUG PA21 and Losartan with Food
- DRUG No PA21; Losartan with food
- DRUG PA21 with food and Losartan 2 hours later
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2011-03 |
| Est. Completion | 2011-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01324752
The ClinicalTrials.gov registry entry for NCT01324752 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vifor Pharma, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which PA21 and Losartan with Food is the first listed.
NCT01324752 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01324752 about?
NCT01324752 is a clinical study titled "A Drug-Drug Interaction Study of Losartan and PA21". The purpose of this study is to determine if Losartan potassium is affected by PA21.
What is the current status of trial NCT01324752?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2011-03. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01324752?
The interventions under investigation include: PA21 and Losartan with Food (DRUG), No PA21; Losartan with food (DRUG), PA21 with food and Losartan 2 hours later (DRUG).
Who is sponsoring clinical trial NCT01324752?
This trial is sponsored by Vifor Pharma, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.